204 related articles for article (PubMed ID: 16284303)
21. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action.
Thomas D; Hammerling BC; Wu K; Wimmer AB; Ficker EK; Kirsch GE; Kochan MC; Wible BA; Scholz EP; Zitron E; Kathöfer S; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J
Br J Pharmacol; 2004 Jun; 142(3):485-94. PubMed ID: 15148258
[TBL] [Abstract][Full Text] [Related]
23. Blockade of the human ether-a-go-go-related gene potassium channel by ketamine.
Zhang P; Xing J; Luo A; Feng J; Liu Z; Gao C; Ma J
J Pharm Pharmacol; 2013 Sep; 65(9):1321-8. PubMed ID: 23927470
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of the HERG channel by droperidol depends on channel gating and involves the S6 residue F656.
Luo T; Luo A; Liu M; Liu X
Anesth Analg; 2008 Apr; 106(4):1161-70, table of contents. PubMed ID: 18349188
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological removal of human ether-à-go-go-related gene potassium channel inactivation by 3-nitro-N-(4-phenoxyphenyl) benzamide (ICA-105574).
Gerlach AC; Stoehr SJ; Castle NA
Mol Pharmacol; 2010 Jan; 77(1):58-68. PubMed ID: 19805508
[TBL] [Abstract][Full Text] [Related]
26. Molecular determinants of cocaine block of human ether-á-go-go-related gene potassium channels.
Guo J; Gang H; Zhang S
J Pharmacol Exp Ther; 2006 May; 317(2):865-74. PubMed ID: 16397089
[TBL] [Abstract][Full Text] [Related]
27. Kinetic model for NS1643 drug activation of WT and L529I variants of Kv11.1 (hERG1) potassium channel.
Perissinotti LL; Guo J; De Biase PM; Clancy CE; Duff HJ; Noskov SY
Biophys J; 2015 Mar; 108(6):1414-1424. PubMed ID: 25809254
[TBL] [Abstract][Full Text] [Related]
28. Protriptyline block of the human ether-à-go-go-related gene (HERG) K+ channel.
Jo SH; Hong HK; Chong SH; Choe H
Life Sci; 2008 Jan; 82(5-6):331-40. PubMed ID: 18191158
[TBL] [Abstract][Full Text] [Related]
29. Structural requirements of human ether-a-go-go-related gene channels for block by bupivacaine.
Siebrands CC; Friederich P
Anesthesiology; 2007 Mar; 106(3):523-31. PubMed ID: 17325511
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological rescue of hERG currents carried out by G604S and wide type hERG co-expression.
Huo J; Zhang A; Guo X; Qiang H; Liu P; Bai L; Ma A
Clin Exp Pharmacol Physiol; 2016 Sep; 43(9):851-61. PubMed ID: 27199074
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of cardiac HERG potassium channels by antidepressant maprotiline.
Ferrer-Villada T; Navarro-Polanco RA; Rodríguez-Menchaca AA; Benavides-Haro DE; Sánchez-Chapula JA
Eur J Pharmacol; 2006 Feb; 531(1-3):1-8. PubMed ID: 16423345
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin.
Thomas D; Wimmer AB; Wu K; Hammerling BC; Ficker EK; Kuryshev YA; Kiehn J; Katus HA; Schoels W; Karle CA
Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):462-72. PubMed ID: 15098086
[TBL] [Abstract][Full Text] [Related]
33. Molecular interaction of droperidol with human ether-a-go-go-related gene channels: prolongation of action potential duration without inducing early afterdepolarization.
Schwoerer AP; Blütner C; Brandt S; Binder S; Siebrands CC; Ehmke H; Friederich P
Anesthesiology; 2007 May; 106(5):967-76. PubMed ID: 17457128
[TBL] [Abstract][Full Text] [Related]
34. Computational analysis of the effects of the hERG channel opener NS1643 in a human ventricular cell model.
Peitersen T; Grunnet M; Benson AP; Holden AV; Holstein-Rathlou NH; Olesen SP
Heart Rhythm; 2008 May; 5(5):734-41. PubMed ID: 18452879
[TBL] [Abstract][Full Text] [Related]
35. Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator.
Perry M; Sachse FB; Sanguinetti MC
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13827-32. PubMed ID: 17693551
[TBL] [Abstract][Full Text] [Related]
36. Electrophysiologic characterization of a novel hERG channel activator.
Su Z; Limberis J; Souers A; Kym P; Mikhail A; Houseman K; Diaz G; Liu X; Martin RL; Cox BF; Gintant GA
Biochem Pharmacol; 2009 Apr; 77(8):1383-90. PubMed ID: 19426677
[TBL] [Abstract][Full Text] [Related]
37. Mallotoxin is a novel human ether-a-go-go-related gene (hERG) potassium channel activator.
Zeng H; Lozinskaya IM; Lin Z; Willette RN; Brooks DP; Xu X
J Pharmacol Exp Ther; 2006 Nov; 319(2):957-62. PubMed ID: 16928897
[TBL] [Abstract][Full Text] [Related]
38. Blocking of the human ether-à-go-go-related gene channel by imatinib mesylate.
Dong Q; Fu XX; Du LL; Zhao N; Xia CK; Yu KW; Cheng LX; Du YM
Biol Pharm Bull; 2013; 36(2):268-75. PubMed ID: 23196655
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of hERG channel block by the psychoactive indole alkaloid ibogaine.
Thurner P; Stary-Weinzinger A; Gafar H; Gawali VS; Kudlacek O; Zezula J; Hilber K; Boehm S; Sandtner W; Koenig X
J Pharmacol Exp Ther; 2014 Feb; 348(2):346-58. PubMed ID: 24307198
[TBL] [Abstract][Full Text] [Related]
40. Investigating the utility of adult zebrafish ex vivo whole hearts to pharmacologically screen hERG channel activator compounds.
Hull CM; Genge CE; Hobbs Y; Rayani K; Lin E; Gunawan M; Shafaattalab S; Tibbits GF; Claydon TW
Am J Physiol Regul Integr Comp Physiol; 2019 Dec; 317(6):R921-R931. PubMed ID: 31664867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]